CD19+CD24hiCD38hi regulatory B cells: a potential immune predictive marker of severity and therapeutic responsiveness of HCV infection
Fang Q.Liang R.Mei Y.Hu Z.Wang J.Sun J.Zhang X.Bellanti J.A.Zheng S.G.
The Third Affiliated Hospital at Sun Yat-Sen University, Department of Clinical ImmunologyThe Third Affiliated Hospital at Sun Yat-Sen University, Department of Infectious DiseasesOhio State University College of Medicine and Wexner Medical Center, Department of Internal MedicineHospital of Stomatology, Sun Yat-sen University, Guanghua School of StomatologyGeorgetown University Medical Center, Department of Pediatrics and Microbiology-Immunology
摘要：＜正＞Background: Hepatitis C virus（HCV） infection is associated with abnormal immune responses. Since regulatory T and B cells modulate the progression of infectious and inflammatory diseases, this study aimed at examining how these cells are involved with the development and progression of HCV
会议名称：
第十七届国际免疫学大会
会议时间：
2019-10-19
会议地点：
中国北京
- 专辑：
医药卫生科技
- 专题：
感染性疾病及传染病; 消化系统疾病
- DOI：
10.26914/c.cnkihy.2019.009133
- 分类号：
R512.63
引文网络
- 参考文献
- 引证文献
- 共引文献
- 同被引文献
- 二级参考文献
- 二级引证文献
相关推荐
- 相似文献
- 读者推荐
- 相关基金文献
- 关联作者
- 相关视频
